Does RANOLAZINE Cause Muscular weakness? 57 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Muscular weakness have been filed in association with RANOLAZINE (Ranolazine). This represents 0.6% of all adverse event reports for RANOLAZINE.
57
Reports of Muscular weakness with RANOLAZINE
0.6%
of all RANOLAZINE reports
1
Deaths
18
Hospitalizations
How Dangerous Is Muscular weakness From RANOLAZINE?
Of the 57 reports, 1 (1.8%) resulted in death, 18 (31.6%) required hospitalization, and 3 (5.3%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which RANOLAZINE Alternatives Have Lower Muscular weakness Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ